CTRI/2018/02/012148RecruitingPhase 2
The Role of Fecal Microbiota Transplantation for maintenance of remission in patients with ulcerative colitis
Arshdeep Singh0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Confirmed Ulcerative Colitis patients who are in clinical remission (defined as complete resolution of symptoms) for a minimum duration of 6 months.
- •2. Patients must be on stable medication regimen for at least 6 months prior to enrollment.
- •3. Able to give informed consent and/or assent as appropriate
Exclusion Criteria
- •1. Patients with active disease
- •2. Patients having toxic megacolon
- •3. Treatment naïve patients
- •4. Pregnant and lactating ladies
- •5. Prior colectomy
- •6. Positive stool test for any of the following: Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacter, E. coli by standard stool culture.
- •7. Regular probiotic supplement use within prior 4 weeks to enrollment
- •8. Severe immunodeficiency, inherited or acquired (e.g. HIV, chemotherapy, or radiation therapy)
- •9. Patients unwilling or unable to give consent or participate in all study requirements
Investigators
Similar Trials
Not yet recruiting
Phase 2
Stool transplant for treatment of colitis and crohns diseaseCTRI/2021/03/032131Dayanand Medical College and Hospital
Not yet recruiting
Phase 3
Fecal Therapy for ColitisCTRI/2021/03/032332Dayanand Medical College and Hospital
Completed
Not Applicable
Efficacy of fecal microbiota transplantation for steroid resistant/ dependent acute graft-versus-host disease of gut, a phase II trial.Steroid resistant/dependent acute graft-versus-host disease of gut after allogeneic hametopoietic stem cell transplantation or donor lymphocyte infusionJPRN-UMIN000020091Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital17
Recruiting
Phase 2
A-FMT for active UCMild to moderate ulcerative colitisUlcerative colitisJPRN-jRCTs031220542agahara Akihito37
Unknown
Phase 3
Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseConstipation (Excl Faecal Impaction)Ulcerative ColitisCrohn DiseaseNCT02575040Saglik Bilimleri Universitesi Gulhane Tip Fakultesi60